These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36327286)

  • 1. Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    Na SJ; Yang JH; Ko RE; Chung CR; Cho YH; Choi KH; Kim D; Park TK; Lee JM; Song YB; Choi JO; Hahn JY; Choi SH; Gwon HC
    PLoS One; 2022; 17(11):e0277087. PubMed ID: 36327286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine versus norepinephrine in the treatment of shock.
    Nathan Coxford R; Lang E; Dowling S
    CJEM; 2011 Nov; 13(6):395-7. PubMed ID: 22436478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dopamine and norepinephrine in the treatment of shock.
    De Backer D; Biston P; Devriendt J; Madl C; Chochrad D; Aldecoa C; Brasseur A; Defrance P; Gottignies P; Vincent JL;
    N Engl J Med; 2010 Mar; 362(9):779-89. PubMed ID: 20200382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Outcomes with Initial Norepinephrine or Epinephrine for Hemodynamic Support After Return of Spontaneous Circulation.
    Weiss A; Dang C; Mabrey D; Stanton M; Feih J; Rein L; Feldman R
    Shock; 2021 Dec; 56(6):988-993. PubMed ID: 34172611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
    J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
    Fawzy A; Evans SR; Walkey AJ
    Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review.
    Lawson CK; Faine BA; Rech MA; Childs CA; Brown CS; Slocum GW; Acquisto NM; Ray L;
    Am J Emerg Med; 2024 Mar; 77():158-163. PubMed ID: 38150986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and effect of vasopressors after pediatric traumatic brain injury.
    Di Gennaro JL; Mack CD; Malakouti A; Zimmerman JJ; Armstead W; Vavilala MS
    Dev Neurosci; 2010; 32(5-6):420-30. PubMed ID: 21124016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dopamine and norepinephrine in shock.
    De Santis V; Nencini C; Tritapepe L
    N Engl J Med; 2010 Jun; 362(24):2329; author reply 2330-1. PubMed ID: 20560160
    [No Abstract]   [Full Text] [Related]  

  • 17. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressors for hypotensive shock.
    Lampard JG; Lang E
    Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA; Lee T; Singer J; De Backer D; Annane D
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.